… The actions of 14-amino acid and 28-amino acid are … protection with concurrent amino acid
infusion is usually given (9)… a combination of 177 Lu-DOTATATE and 90 Y-SSAs can result in …

… Radionuclide Therapy) is a promising modality treatment for … the goal of receptor-mediated
radiometabolic therapy and the … of [ 90 Y]Y-DOTATOC has decreased by 65% intravenous …

… hour before therapy and over 2 h after therapy. The amino acid infusion is associated with
… The duration of the nephroprotective infusion of amino acids after Yttrium-90-labelled PRRT …

… Treatment with 90 Y-DOTATOC stopped rapid tumor … is replaced by the natural amino acid
Thr. This somatostatin analog was … despite the lack of receptor-mediated internalization (127). …

… with 90 Y-DOTATOC [43]. Patients received up to four cycles of … associated with a better
survival after treatment with 90 … to the nephroprotective amino acid infusion. Transient grade 3 or …

… by administering a positively charged amino acid infusion (L-… failure of other treatments,
the European Society for Medical … NETs resistant to SSAs and tandem therapy with [ 90 Y]Y-/[ …

… . Receptor-mediated radionuclide therapy with 90 Y-DOTATOC in association with amino
acid infusion: a phase I study. Eur J Nucl Med Mol Imaging. 2003;30:207–216. …

… 177 Lu-DOTATATE, 90 Y-DOTATOC or a combination of these … by the concurrent infusion
of an amino acid combination, … with concomitant amino acid infusion and exclusion of patients …

… to the renoprotective amino acid infusion that is concurrently … MTC was associated with
response to therapy in 29% of the … ATC, and 90 Y-DOTATOC therapy failed to achieve an …

… associated with amino acid infusions that patients also received, and which resolved after
completion of the infusions. … renal AE, whereas 90 Y-DOTATOC monotherapy was identified as …